Article guide

Reducing harm from drug use

Guide contents

Someone may not be ready to stop using drugs, may be unsure what they want next, or may already be looking for treatment. Their health matters now in each of these situations. Harm reduction aims to lessen real dangers and open a route to care without first requiring a promise to “manage it alone.” It does not make drug use safe or replace treatment. Its purpose is to protect more possibilities for life and for the next decision.

If a person cannot be awakened, is breathing slowly or with difficulty, may have overdosed, or is in immediate danger for another reason, contact your local emergency medical service at once. Do not wait to identify the substance or replace emergency care with this article, the questions below, or a routine appointment. If naloxone is available under local rules and an opioid overdose is possible, follow the instructions for that specific authorized product and the emergency dispatcher's directions; stay with the person until help arrives if it is safe to do so. While waiting, if safe and consistent with the dispatcher's directions, place the person on their side to reduce the risk of choking. Naloxone addresses the opioid component and its effect is temporary: medical care is still needed afterward. These boundaries follow CDC guidance on a suspected overdose.

Questions explored

1. What harm reduction means in practice

It is usually a combination of available routes rather than a single trick: emergency care for immediate danger, infection prevention, overdose preparation, a medical assessment, and access to treatment. One person may most need to check their health now. Another may want to find out whether an opioid overdose reversal medicine is available. A third may need a clinician who will listen without moral judgment. These needs do not have to wait in a fixed order.

The WHO describes harm reduction for people who inject drugs as part of wider care that includes testing, treatment, and support. This is a description of a range of services, not a claim that all of them exist in every town. Risks and appropriate services may differ with other patterns of drug use; a qualified professional can help relate them to the person's situation.

A person may feel that using brings relief, energy, or a sense of belonging. That experience deserves to be heard. It is also important to look at actual effects on breathing, sleep, health, money, safety, and relationships. Neither a perceived benefit nor shame by itself establishes a diagnosis or determines which help is needed.

2. Choosing a first route without a perfect plan

If danger is present now, emergency medical care comes first. Otherwise, begin with the closest known risk. A possible infection exposure or questions about vaccination call for a local medical or prevention contact. Concern about overdose calls for checking local access to naloxone and training in its use. Repeated harmful consequences call for a professional assessment and a discussion of treatment options.

These routes are not a ladder on which someone must earn the next step. Testing and infection care can happen alongside a conversation about drug use. Considering treatment does not remove the need for overdose prevention. If one service cannot provide what is needed, ask for a specific referral, the expected timing, and a way to reach the next service. Having an appointment is not the same as having received care.

Cost, waiting times, transport, language, worries about disclosure, or the way staff treat people may make access difficult. A barrier is a reason to look for another available route or support from a community organization; it is not evidence that the person does not need help. Check conditions with a local service instead of assuming that a foreign source describes your area.

3. Infection prevention should fit the actual risk

When drug use involves injection, reused or shared equipment can transmit blood-borne infections. Where lawful and available, syringe service programs can connect access to sterile supplies and safe disposal with testing, vaccination, and referrals for treatment. CDC describes these functions in the United States; local availability must be checked separately. The point is to prevent infection and create a link to health care, not to instruct anyone how to use drugs.

Questions for a health professional may include HIV and viral hepatitis testing, whether hepatitis A or B vaccination is appropriate, and what follow-up care is available if a result is positive. The appropriate tests and vaccinations depend on the person's history, the risk involved, and local clinical guidance. This article does not prescribe them for an individual. Signs of a serious acute illness need medical assessment without waiting for a routine prevention visit.

Not everyone who uses drugs injects them. Do not assume a route of use, an infection, or a diagnosis. It is more useful to ask what prevention or health care the person actually needs and how they would like to access it.

4. Preparing for a possible overdose

Naloxone can reverse the effects of opioids in an overdose, including an overdose involving a prescribed opioid medicine. The FDA stresses that its effect is temporary and emergency medical care is still necessary. It is not a universal remedy for every substance. An unknown composition or a mixture of substances is not a reason to postpone calling for help: the person's condition matters more than a guess about what was taken.

Before an emergency, a person can ask a local health service, pharmacy, or community program whether authorized naloxone is available, who can receive it, under what conditions, and whether training is offered to an adult close to them. Rules of supply, cost, and stock vary. Knowing about the medicine does not guarantee protection for oneself or someone else. Use a specific product according to its approved instructions and local emergency directions, rather than a general article.

At the time of a suspected overdose, an adult witness does not have to make a diagnosis. Contacting the local emergency service, following the dispatcher's directions, and remaining with the person until help arrives, where safe, matter most. Do not make a child responsible for recognizing an overdose or replacing adults and medical staff. Do not drive while intoxicated to seek help.

5. Medical care and treatment need not start from the same goal

Harm reduction and treatment can work together. Someone may have questions about their health, repeated consequences, mental health, or changing their drug use. CDC describes treatment for substance use disorders as care matched to clinical needs; medication and other forms of treatment are available for opioid use disorder. A qualified assessment is needed to choose an approach. A general article cannot make that choice for a person.

Using a substance, taking a prescribed medicine, or developing physical adaptation to it does not by itself establish a substance use disorder. Discuss changes to prescribed medication with the treating clinician; do not stop or change it on the basis of this article. Nor should someone have to prove complete abstinence before receiving care for an infection, pain, or overdose risk.

A first request can be simple: “I need help assessing my health risks and the care available here. Where can I begin?” A clinician or service can distinguish an emergency from a routine visit and explain options within that local health system.

6. Five optional prompts for a conversation

These prompts are for facts already known to the person. “I don't know” is an acceptable answer, and any prompt can be skipped. Preparing answers must not delay emergency help or become a condition of care.

  1. What is happening now: is there a known symptom or situation that calls for emergency care rather than a routine appointment?
  2. Which harm matters most to prevent: overdose, infection, deterioration of another condition, or consequences in everyday life?
  3. What is already known about health: which earlier visits, prescribed medicines, vaccinations, or test results does the person consider useful to tell a professional?
  4. What care is actually accessible: is a local service, pharmacy, or health contact known, and what needs checking about language, cost, timing, and privacy?
  5. What is the next question: does the person want an assessment, prevention services, treatment, a referral, or an explanation of options?

7. Checking what is available locally

A regular health facility, local community infection-prevention organization, or substance-use service may be a starting point if one operates in your area. The first call need not include a full personal history: “Do you offer advice about overdose and infection risks? Is testing, vaccination, or a referral available? How do I arrange a visit, and what can I do if the wait is long?” In immediate danger, this route does not replace emergency care.

Ask whether the service is taking new people, what it costs, which languages it offers, what information it requires, and how personal information is handled. Do not assume a service is free, anonymous, or lawful in your region; these are local facts to verify. If it cannot help, ask for another reachable contact and how to get there. Avoid sending unnecessary personal documents or someone else's details through an unverified channel.

After booking, check what happened: did the visit occur, were needed tests carried out, was the result explained, and is the next contact clear? If care did not happen, the access problem remains real and another route may be needed. The number of calls made or a referral on paper alone does not show that care was received.

8. If someone does not want to change their use yet

Prevention can still have value without a promise to stop using drugs. A conversation about testing, vaccination, access to naloxone, or symptoms should not become punishment for lacking a final plan. Someone may consider treatment later or ask for an assessment now. Medical care does not require first finding a perfect purpose in life, relationship, or environment.

This does not mean risk disappears when someone decides merely to “be careful.” If harms recur or circumstances change, reassess the support and medical care needed. The benefit a person feels from using deserves a serious conversation, but it does not create immunity from infection, overdose, or other harms. The practical aim is to reduce a specific danger and widen real choices, not win a dispute over the right label.

9. Family and friends: consent and boundaries

An adult close to the person can offer to find a local route, help make an appointment or accompany them, and ask whether they want to discuss naloxone and an emergency response plan. Agree on roles in advance and allow them to be refused or revised. Secretly changing prescribed medicines, controlling a phone, or making threats does not become health care by being called concern.

Helpers may also protect their own money, sleep, and safety and seek support for themselves. A child must not be made a monitor of an adult's drug use, breathing, or mood. Threats, coercion, or violence require a separate route to protection and may be urgent; that protection does not depend on a diagnosis, acknowledgment of a problem, or agreement to treatment.

Family members cannot replace clinicians and emergency services on their own. Support may make contact easier, but it cannot guarantee another person's choice or outcome. Clear boundaries make that reality easier to live with, without blaming anyone.

10. The next step is measured by care received

After the first conversation, ask: did the person get the assessment they needed, learn where to turn in an emergency, gain access to infection prevention or treatment, and understand the next contact? If not, the next step is finding a service that can answer. If the condition worsens, seek medical help before a planned follow-up; use emergency services for immediate danger.

Harm reduction leaves room for change. Someone may later choose treatment, begin with a health check, or accept help from someone close to them. None of these steps requires proving strong character or deciding the rest of life in advance. Naming one real risk and finding a local contact that can help reduce it now is enough to begin.

Sources and limits

Tags

harm reduction, drug use, access to care, overdose prevention, naloxone, opioids, infection prevention, testing, vaccination, addiction treatment, local services, helper boundaries

About the authors

Andrey Zarinsh — author and founder of United Wisdom. He explores inner transformation, the unity of traditions, cross-cultural dialogue, and contemporary spiritual discipline. Instagram: @andrey.zarinsh.

Maria Evilkut — co-author of United Wisdom. Alongside her research, she seeks to test these ideas in practice and observe how the principles of unity and mutual understanding work in real life between people and cultures. Instagram: @ilkutki.

Content reviewed: 14 October 2026. Language version: EN.

Limits of interpretation

  • This local GEO representation applies only to the specified source article version and its SHA-256.
  • Qualifications, sources and attributions remain in the full sections and byte-identical Markdown copy.
  • No new source research was conducted in this GEO stage.

Sources

  • CDC, What to Do If You Think Someone Is Overdosing

    - [CDC, What to Do If You Think Someone Is Overdosing](https://www.cdc.gov/stop-overdose/response/) — April 2, 2024; US first-response page. Emergency principles are presented without the US phone number or legal assurances.

  • WHO, People who inject drugs

    - [WHO, People who inject drugs](https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/populations/people-who-inject-drugs) — official global topic page; no substantive update date shown. A range of services mainly for people who inject drugs, not a promise of local availability.

  • CDC, Viral Hepatitis Among People Who Use or Inject Drugs

    - [CDC, Viral Hepatitis Among People Who Use or Inject Drugs](https://www.cdc.gov/hepatitis/hcp/populations-settings/pwid.html) — September 12, 2025; US clinical page. Testing, vaccination, and infection prevention services, not a personal testing or vaccination schedule.

  • FDA, Access to Naloxone Can Save a Life During an Opioid Overdose

    - [FDA, Access to Naloxone Can Save a Life During an Opioid Overdose](https://www.fda.gov/consumers/consumer-updates/access-naloxone-can-save-life-during-opioid-overdose) — official US page; no update date shown in the page read. Opioid-specific and temporary effect, not local supply rules.

  • CDC, Treatment of Substance Use Disorders

    - [CDC, Treatment of Substance Use Disorders](https://www.cdc.gov/overdose-prevention/treatment/index.html) — April 25, 2024; US public information. Assessment and treatment options, not a reader's diagnosis or individual prescription.